Werewolf Therapeutics
Stock Forecast, Prediction & Price Target
Werewolf Therapeutics Financial Estimates
Werewolf Therapeutics Revenue Estimates
Werewolf Therapeutics EBITDA Estimates
Werewolf Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $16.40M 0% | $19.94M 21.59% | Avg: $12.03M Low: $471.85K High: $23.59M avg. -39.66% | Avg: $12.5M Low: $2.46M High: $24.63M avg. 3.88% | Avg: $12.45M Low: $2.45M High: $24.53M avg. -0.4% | Avg: $75.38M Low: $14.85M High: $148.57M avg. 505.53% |
Net Income
% change YoY
| $-49.76M N/A | $-51.56M -3.61% | $-37.36M 27.53% | Avg: $-70.32M Low: $-64.87M High: $-32.43M avg. -88.18% | Avg: $-86.88M Low: $-73.78M High: $-39.56M avg. -23.54% | Avg: $-72.98M Low: $-165.08M High: $3.19M avg. 15.99% | Avg: $-67.25M Low: $-152.13M High: $2.94M avg. 7.84% |
EBITDA
% change YoY
| $-50.08M N/A | $-56.05M -11.91% | $-32.46M 42.08% | Avg: $2.40M Low: $94.36K High: $4.71M avg. 107.41% | Avg: $2.49M Low: $492.70K High: $4.92M avg. 3.88% | Avg: $2.48M Low: $490.73K High: $4.90M avg. -0.40% | Avg: $15.07M Low: $2.97M High: $29.71M avg. 505.53% |
EPS
% change YoY
| -$1.82 N/A | -$1.79 1.64% | -$1.05 41.34% | Avg: -$1.49 Low: -$1.82 High: -$0.91 avg. -41.71% | Avg: -$1.6 Low: -$2.07 High: -$1.11 avg. -7.69% | Avg: -$2.05 Low: -$4.63 High: $0.09 avg. -27.75% | Avg: -$1.89 Low: -$4.27 High: $0.08 avg. 7.84% |
Operating Expenses
% change YoY
| $50.08M N/A | $72.45M 44.66% | $60.44M -16.57% | Avg: $12.00M Low: $470.68K High: $23.53M avg. -80.14% | Avg: $12.46M Low: $2.45M High: $24.57M avg. 3.88% | Avg: $12.41M Low: $2.44M High: $24.47M avg. -0.40% | Avg: $75.20M Low: $14.82M High: $148.21M avg. 505.53% |
FAQ
What is Werewolf Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -21.97% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -64.87M, average is -70.32M and high is -32.43M.
What is Werewolf Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 117.33% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $471.85K, average is $12.03M and high is $23.59M.
What is Werewolf Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -17.33% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$1.82, average is -$1.49 and high is $-0.91.
What is the best performing analyst?
In the last twelve months analysts have been covering Werewolf Therapeutics stock. The most successful analyst is Reni Benjamin.